Cargando…

Efficacy and Safety of Different Dosage of Recombinant Tissue-type Plasminogen Activator (rt-PA) in the Treatment of Acute Pulmonary Embolism: A Systematic Review and Meta-analysis

Reperfusion therapies are recommended for patients with hemodynamic instability or high-risk acute pulmonary embolism (PE). Lower doses of tissue plasminogen activator (rt-PA) could be considered to improve bleeding complications. The aim of this study was to evaluate the efficacy and safety of a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amini, Shahideh, Bakhshandeh, Hooman, Mosaed, Reza, Abtahi, Hamidreza, Sadeghi, Kourosh, Mojtahedzadeh, Mojtaba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457724/ https://www.ncbi.nlm.nih.gov/pubmed/34567173 http://dx.doi.org/10.22037/ijpr.2021.114142.14688

Ejemplares similares

Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis
por: Shahrami, Bita, et al.
Publicado: (2020)

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
por: Shirazy, Mohamed, et al.
Publicado: (2019)

Feasibility study and determination of prerequisites of telecare programme to enhance patient management in lung transplantation: a qualitative study from the perspective of Iranian healthcare providers
por: Gholamzadeh, Marsa, et al.
Publicado: (2023)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
por: Shibata, Soichiro, et al.
Publicado: (2022)

Effect of Oral Anticoagulant Therapy on Coagulation Activity and Inflammatory Markers in Patients with Atrial Fibrillation Undergoing Ablation: A Randomized Comparison between Dabigatran and Warfarin
por: Amini, Shahideh, et al.
Publicado: (2013)

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke
por: Yang, Jie, et al.
Publicado: (2016)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
por: Chowdary, Pratima, et al.
Publicado: (2023)

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model
por: Crumrine, R Christian, et al.
Publicado: (2011)

Design and evaluation of a Mobile-Based decision support system to enhance lung transplant candidate assessment and management: knowledge translation integrated with clinical workflow
por: Abtahi, Hamidreza, et al.
Publicado: (2023)

Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest
por: Dirican, Adem, et al.
Publicado: (2014)

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
por: Lee, J. H., et al.
Publicado: (1996)

Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
por: Peng, Tao, et al.
Publicado: (2023)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

The effect of parenteral selenium on outcomes of mechanically ventilated patients following sepsis: a prospective randomized clinical trial
por: Chelkeba, Legese, et al.
Publicado: (2015)

The Effect of High-dose Parenteral Sodium Selenite in Critically Ill Patients following Sepsis: A Clinical and Mechanistic Study
por: Chelkeba, Legese, et al.
Publicado: (2017)

Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial
por: Richtrova, Pavlina, et al.
Publicado: (2021)

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial
por: Shahrami, Bita, et al.
Publicado: (2016)

Case series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome
por: Amini, Shahideh, et al.
Publicado: (2022)

Recombinant human erythropoietin reduces plasminogen activator inhibitor and ameliorates pro-inflammatory responses following trauma
por: Shiehmorteza, M., et al.
Publicado: (2011)

Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial
por: Wang, Hai-bo, et al.
Publicado: (2017)

Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017)

Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke
por: Chen, Jing, et al.
Publicado: (2023)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke
por: Orset, Cyrille, et al.
Publicado: (2021)

Is Albumin-based Resuscitation in Severe Sepsis and Septic Shock Justifiable? An Evidence from a Cost-effectiveness Evaluation
por: Tigabu, Bereket, et al.
Publicado: (2019)

Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism
por: Hoang, Bui Hai, et al.
Publicado: (2021)

Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions
por: Daruich, Alejandra, et al.
Publicado: (2016)

The effect of prehospital notification by emergency medical service on outcomes in patients receiving recombinant tissue-type plasminogen activator (r-tPA)
por: Rafie, Shahram, et al.
Publicado: (2022)

High-dose amikacin for achieving serum target levels in critically ill elderly patients
por: Sadeghi, Kourosh, et al.
Publicado: (2018)

Safety evaluation of a recombinant plasmin derivative lacking kringles 2–5 and rt-PA in a rat model of transient ischemic stroke
por: Crumrine, R Christian, et al.
Publicado: (2012)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA)
por: Torres-Paris, Constanza, et al.
Publicado: (2023)

Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism -A case report-
por: Kim, Min Soo, et al.
Publicado: (2010)

Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
por: Rashidi, Farid, et al.
Publicado: (2022)

Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

rt‐PA with remote ischemic postconditioning for acute ischemic stroke
por: Che, Ruiwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hdb74spfd3u4mmherurjoj2jhu